20
Participants
Start Date
September 30, 2011
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Tadalafil Citrate
If allocated to the treatment arm, the patient will be given tadalfil citrate, 0.8-1 mg/kg/day in 1 daily dose. Maximum dose 40 mg. All patients will receive either study drug or placebo for a total of 20 days.
Sugar pill
If allocated to the placebo arm, the child will be given a similar appearing medication; the placebo will be a mixture of Ora-Sweet® and Ora-Plus® in a 1:1 ratio. All patients will receive drug for 20 days
Primary Childrens Medical Center, Salt Lake City
University of Utah
OTHER